Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) Financials
1752.TW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2024 | 3.8 billion | 1.4 billion |
| Sept. 30, 2024 | 3.5 billion | 1.2 billion |
| June 30, 2024 | 3.6 billion | 1.4 billion |
| March 31, 2024 | 3.6 billion | 1.4 billion |
1752.TW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2024 | -55.6 million | ? |
| Sept. 30, 2024 | 106.8 million | ? |
| June 30, 2024 | -118.6 million | ? |
| March 31, 2024 | 8.0 million | ? |
1752.TW Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2024 | 92.0 million |
| Sept. 30, 2024 | 76.3 million |
| June 30, 2024 | 44.1 million |
| March 31, 2024 | 70.1 million |
1752.TW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2024 | 303.4 million | 167.6 million | 1.1 million |
| Sept. 30, 2024 | 230.7 million | 6.8 million | 1.3 million |
| June 30, 2024 | 244.6 million | 106.3 million | 95000 |
| March 31, 2024 | 228.1 million | 112.6 million | 324000 |
1752.TW Shares Outstanding
1752.TW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2024 | 250.2 million | 46.7 million | 70.4 million | 41.8 million |
| Sept. 30, 2024 | 25.6 million | 42.1 million | 69.7 million | 41.6 million |
| June 30, 2024 | 181.8 million | 38.6 million | 57.4 million | 36.9 million |
| March 31, 2024 | 67.9 million | 41.8 million | 66.2 million | 36.6 million |
1752.TW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2024 | 579.2 million | 359.2 million |
| Sept. 30, 2024 | 579.9 million | 383.3 million |
| June 30, 2024 | 512.3 million | 359.7 million |
| March 31, 2024 | 528.5 million | 357.0 million |
1752.TW
Price: NT$33.70
Dividend Yield: 4.32%
Forward Dividend Yield: 4.75%
Payout Ratio: 183.49%
Dividend Per Share: 1.60 TWD
Earnings Per Share: 2.54 TWD
P/E Ratio: 14.57
Exchange: TAI
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 3.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 9
DGR3: -21.80%